Collectively, our data illustrates that inhibition of AKT pathway in GIST and STS attenuates homology-mediated DNA repair and sensitizes tumor cells to the DNA-damaging agents, such as doxorubicin. This evidence concerns the gene AKT1 and telomere syndrome.